维普中文期刊产品整合服务
22篇 您的检索式:作者名="Paul MN"
    题名 作者 年代 出处 被引量
1Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance显示文摘The Hepatitis B Virus(HBV) has a worldwide distribu-tion and is endemic in many populations. It is constantly evolving and 10 genotypic strains have been identified with varying prevalences in different geographic regions. Numerous stable mutations in the core gene and in the su-rface gene of the HBV have also been identified in untreated HBV populations. The genotypes and viral variants have been associated with certain clinical featu-res of HBV related liver disease and Hepatocellu-lar carcinoma. For example Genotype C is associated withlater hepatitis B e antigen(HBe Ag) seroconversion, and more advanced liver disease. Genotype A is associated with a greater risk of progression to chronicity in adu-lt acqu-ired HBV infections. Genotype D is particu-larly associated with the precore mu-tation and HBe Ag negative chronic hepatitis B(CHB). The genotypes prevalent in parts of West Africa, Central and Sou-th America, E, F and H respectively, are less well stu-died. Viral variants especially the Basal Core Promotor mutation is associated with increased risk of fibrosis and cancer of the liver. Althou-gh not cu-rrently part of rou-tine clinical care, evalu-ation of genotype and viral variants may provide u-sefu-l adju-nctive information in predicting risk abou-t liver related morbidity in patients with CHB.Catherine MN Croagh Paul V Desmond Sally J Bell 2015World Journal of Hepatology2015,7,3:24
2Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of pa- tients with advanced breast cancer: a phase 11, randomized, open-label trial 显示文摘Robert NJ Saleh MN Paul D 2011Clin Breast Cancer2011,11,2:1
3Sunitinib plus pacli- taxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase IlI, randomized, open-label trial显示文摘Robert NJ Saleh MN Paul D 2011Clin Breast Cancer2011,11,2:1
4A- bility of MBP or RBP signal peptides to influence folding and in vitro translocation of wild-type and hybrid precursors显示文摘ROSEMOND J C SHARON MN M S PAUL H R 1994FEBS Letters1994,349,2:1
5A study on interferon-gamma(IFN-gamma)response by Tcells stimulated by hepatitis B virus core antigen显示文摘Paul S Tabassum S Islam MN 2004Bangladesh Med Res Counc Bull2004,30,:1
6Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection 显示文摘Paul S Tabassum S Islam MN 2004Bangladesh Med Res Counc Bull2004,30,2:1
7Review of facilitated approaches to vascular anastomosis surgery显示文摘Paul MN Werker Moshe K 1997Ann Thorac Surg1997,63,:1
8Long-term results of local excision for rectal cancer显示文摘Philip BP Garrett MN Paul B 2002Ann Surg2002,236,4:1
9Sunitinib plus paclitaxel ver- sus bevaeizumab plus paclitaxel for first - line treatment of pa- tients with advanced breast cancer: a phase III, randomized, open -label trial显示文摘Robert N J Saleh MN Paul D 2010Cancer2010,136,18:1
10PET and SPECT imaging in psychiatry disorders显示文摘Robert Z Jeffrey MN Paul V 2007Can J Psychiatry2007,52,3:1
11Approach and considerations regarding the patient with spinal injury显示文摘Paul LC Adrian MN 2005Care Injured2005,36,1:1
12Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder:incidence and risk factors显示文摘Paul DS Pablo G Alan MN 2004BJU Int2004,94,6:1
13Synergistic proinflammatory re- sponses induced by polymicrobial colonization of epithelial surfaces 显示文摘Ratner AJ' Lysenko ES Paul MN 2005Proc Natl Acad Sci USA2005,102,9:1
14Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase Ill , randomized, open-label trial显示文摘Robert NJ Saleh MN Paul D 2011Clin Breast Cancer2011,11,2:1
15Sunitinib plus paclitaxelversus bevacizumab plus paclitaxel for first-line treatment ofpatients with advancedbreast cancer: a phase IH,randomized,open-label trial 显示文摘Robert NJ Saleh MN Paul D 2011Clin Breast Cancer2011,11,2:1
16Interferon-gamma (IFN-gamma) response to different hepatitis B virusantigens in hepatitis B virus infection显示文摘Paul S Tabassum S Islam MN 2004Bangladesh Med Res Counc Bull2004,30,:1
17Sunitinib plus paclitaxel versus be- vacizumab plus paelitaxel for first-line treatment of patients with advanced breast cancer:a phase HI ,randomized,open-label trial 显示文摘Robert NJ Saleh MN Paul D 2011Clin Breast Cancer2011,11,2:1
18Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled triall 显示文摘Kenneth FA Paul DL Katherine MN 2005America Journal Chnic Nutrition2005,82,:1
19Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced b~ast cancer : a phase III, randomized, open-label trial显示文摘Robert NJ Saleh MN Paul D 2011Clin Breast Cancer2011,11,2:1
20Long-term results of local excision for rectal cancer显示文摘Philip BP Garrett MN Paul B 2002Ann Surg2002,236,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费